Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 6,376 shares at $32.00 ($198K) on 2013-09-10, disclosed to the SEC on 2013-09-10.
Scheduled sale ($198k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 3,188 | $96K | 48.4% |
| 2 | $32.00 | 3,188 | $102K | 51.6% |
| Total | $31.00 avg | 6,376 | $198K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |